NASDAQ · USD
BioVie Inc. (BIVIW) Stock Analysis
BioVie Inc. (BIVIW) is a stock listed on NASDAQ and quoted in US Dollar.
$0.33
−$0.03 (−8.33%)
Sep 4, 2026 · Market close
This is a derivative instrument — a warrant on BioVie Inc. (BIVI) common stock.
Issuer fundamentals are shown on the issuer page, not here.
View BIVI →Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
BIVIW Key Statistics
As of Sep 4, 2026Trading
- Open
- $0.32
- Previous Close
- $0.36
- Day's Range
- 0.32–0.35
- 52-Week Range
- 0.32–0.35
- Volume
- 8.41K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.74
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
BIVIW Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −3.23% |
| 2025 (partial year) | +0.00% |
As of September 4, 2026.
Recent News
BioVie completes final patient visit in Phase 2 Long COVID trial
YahooBioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
YahooBioVie Inc. (BIVI) Discusses Bezisterim Mechanism of Action and SUNRISE-PD Phase II Trial Design Transcript
SeekingAlphaJoin Biovie's Exclusive Live Investor Webinar: Inside the SUNRISE-PD Topline Results
YahooBioVie stock sinks on Phase IIb Parkinson’s trial data
YahooBioVie reports positive Phase 2 results for Parkinson's candidate bezisterim
Yahoo
All 8 articles ↓Show fewer ↑
News provided by third-party sources. Not financial advice.





